HUE029459T2 - Methods for the Preparation of Polymorph Form I of Clopidogrel Hydrogen Sulphate - Google Patents
Methods for the Preparation of Polymorph Form I of Clopidogrel Hydrogen Sulphate Download PDFInfo
- Publication number
- HUE029459T2 HUE029459T2 HUE05734224A HUE05734224A HUE029459T2 HU E029459 T2 HUE029459 T2 HU E029459T2 HU E05734224 A HUE05734224 A HU E05734224A HU E05734224 A HUE05734224 A HU E05734224A HU E029459 T2 HUE029459 T2 HU E029459T2
- Authority
- HU
- Hungary
- Prior art keywords
- clopidogrel
- solution
- temperature
- sulfuric acid
- base
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410009028 CN1690060A (zh) | 2004-04-19 | 2004-04-19 | 一种制备i型硫酸氯吡格雷的方法 |
SI200400122A SI21749A (sl) | 2004-04-21 | 2004-04-21 | Postopek za pripravo polimorfne oblike I klopidogrel hidrogen sulfata |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE029459T2 true HUE029459T2 (en) | 2017-02-28 |
Family
ID=34965241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE05734224A HUE029459T2 (en) | 2004-04-19 | 2005-04-19 | Methods for the Preparation of Polymorph Form I of Clopidogrel Hydrogen Sulphate |
Country Status (10)
Country | Link |
---|---|
US (1) | US7999106B2 (fr) |
EP (1) | EP1740593B1 (fr) |
EA (1) | EA010198B1 (fr) |
ES (1) | ES2577303T3 (fr) |
HR (1) | HRP20160757T1 (fr) |
HU (1) | HUE029459T2 (fr) |
NO (1) | NO339878B1 (fr) |
PL (1) | PL1740593T3 (fr) |
SI (1) | SI1740593T1 (fr) |
WO (1) | WO2005100364A1 (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7772398B2 (en) * | 2005-03-11 | 2010-08-10 | Dr. Reddy's Laboratories, Inc. | Process for making crystalline form I of clopidogrel hydrogen sulphate |
US20090093635A1 (en) * | 2006-03-09 | 2009-04-09 | Sandor Garadnay | PROCESS FOR MAKING POLYMORPH FROM I OF (S) - (+) -METHYL-ALPHA- (2-CHLOROPHENYL) -6, 7-DYHIDRO-THIENO- [3, 2-c] PYRIDINE-5 (4H) -ACETATE HYDROGEN SULFATE |
EP1931682A2 (fr) * | 2006-08-03 | 2008-06-18 | Teva Pharmaceutical Industries Ltd. | Procédé de préparation du bisulfate de clopidogrel |
WO2008032995A1 (fr) * | 2006-09-15 | 2008-03-20 | Boryung Pharmaceutical Co., Ltd | Sel de clopidogrel (+)-camphosulfonate, procédé de préparation de ce sel et composition pharmaceutique comprenant ce sel |
SI22383A (sl) * | 2006-09-22 | 2008-04-30 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nov postopek sinteze klopidogrela in nove oblike njegovih farmacevtsko sprejemljivih soli |
WO2008068569A2 (fr) * | 2006-12-01 | 2008-06-12 | Wockhardt Research Centre | Procédés de préparation de chlorhydrate de clopidogrel |
EP2114957A4 (fr) * | 2007-01-29 | 2011-06-08 | Ipca Lab Ltd | Procédé de préparation d'une forme 1 cristalline d'un sulfate d'hydrogène de clopidogrel |
PL382055A1 (pl) * | 2007-03-23 | 2008-09-29 | Koźluk Tomasz Nobilus Ent | Sposób wytwarzania formy krystalicznej 1 wodorosiarczanu klopidogrelu |
EP2107061A1 (fr) * | 2008-04-02 | 2009-10-07 | Krka Tovarna Zdravil, D.D., Novo Mesto | Procédé de préparation de clopidogrel enrichi optiquement |
WO2011042804A2 (fr) | 2009-10-08 | 2011-04-14 | Jubliant Life Sciences Limited | Procédé perfectionné pour la préparation de la forme i d'hydrogénosulfate de clopidogrel |
WO2011051976A2 (fr) * | 2009-10-30 | 2011-05-05 | Matrix Laboratories Ltd | Procédé amélioré de préparation de la forme i du bisulfate de clopidogrel |
WO2011125069A1 (fr) * | 2010-03-22 | 2011-10-13 | Rpg Life Sciences Limited | Procédé de préparation de la forme cristalline i du bisulfate de clopidogrel |
CN103360406A (zh) * | 2012-03-26 | 2013-10-23 | 黑龙江福和华星制药集团股份有限公司 | 一种制备i型硫酸氢氯吡格雷的方法 |
CN102924474B (zh) * | 2012-11-08 | 2015-04-01 | 浙江海翔药业股份有限公司 | 一种氯吡格雷硫酸氢盐晶型ⅰ的制备方法 |
EP3293176B1 (fr) | 2013-10-22 | 2020-12-02 | Chiesi Farmaceutici S.p.A. | Forme crystalline d'un inhibiteur pde4 |
US10238650B2 (en) | 2015-03-06 | 2019-03-26 | Beyondspring Pharmaceuticals, Inc. | Method of treating cancer associated with a RAS mutation |
KR101710922B1 (ko) | 2015-06-03 | 2017-02-28 | 경동제약 주식회사 | 클로피도그렐 황산염 결정형 i형의 제조방법 |
SI3597189T1 (sl) | 2015-06-17 | 2022-08-31 | Otsuka America Pharmaceutical, Inc. | Kristalinične spojine |
AU2016291708B2 (en) | 2015-07-13 | 2020-12-24 | Beyondspring Pharmaceuticals, Inc | Plinabulin compositions |
SG11201806583XA (en) | 2016-02-08 | 2018-09-27 | Beyondspring Pharmaceuticals Inc | Compositions containing tucaresol or its analogs |
CN110431135A (zh) | 2017-01-06 | 2019-11-08 | 大连万春布林医药有限公司 | 微管蛋白结合化合物及其治疗用途 |
KR20190109479A (ko) | 2017-02-01 | 2019-09-25 | 비욘드스프링 파마수티컬스, 인코포레이티드. | 호중구감소증의 감소 방법 |
US11040986B2 (en) | 2017-02-16 | 2021-06-22 | Sandoz Ag | Crystalline forms of cabotegravir sodium |
US11786523B2 (en) | 2018-01-24 | 2023-10-17 | Beyondspring Pharmaceuticals, Inc. | Composition and method for reducing thrombocytopenia |
TW202028208A (zh) | 2018-10-09 | 2020-08-01 | 瑞士商諾華公司 | N-(4-氟-3-(6-(3-甲基吡啶-2-基)-[1,2,4]三唑并[1,5-a]嘧啶-2-基)苯基)-2,4-二甲基㗁唑-5-甲醯胺固體形式 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2623810B2 (fr) | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
FR2779726B1 (fr) | 1998-06-15 | 2001-05-18 | Sanofi Sa | Forme polymorphe de l'hydrogenosulfate de clopidogrel |
WO2002018357A1 (fr) | 2000-08-29 | 2002-03-07 | Rpg Life Sciences Limited | Procede en recipient unique pour preparer des sels d'addition acides pharmaceutiquement acceptables de derives de 4, 5, 6, 7 - tetrahydrothieno (3,2-c) pyridine ayant une activite antithrombotique |
GB0125708D0 (en) | 2001-10-26 | 2001-12-19 | Generics Uk Ltd | Novel compounds and processes |
MXPA04006088A (es) * | 2001-12-18 | 2004-09-27 | Teva Pharma | Polimorfo de sulfato de hidrogeno de clopidogrel. |
US7309710B2 (en) | 2002-08-27 | 2007-12-18 | Astellas Pharma Inc. | Crystals |
CZ297472B6 (cs) * | 2002-08-27 | 2006-12-13 | Zentiva, A.S. | Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I |
WO2004048385A2 (fr) | 2002-11-28 | 2004-06-10 | Instytut Farmaceutyczny | Procede de preparation de la forme cristalline 1 du clopidogrel hydrogene sulfate |
EP1603920A1 (fr) * | 2003-03-12 | 2005-12-14 | Cadila Healthcare Ltd. | Polymorphes et forme amorphe de bisulfate de (s) - (+) -clopidogrel |
KR101155679B1 (ko) | 2003-07-02 | 2012-06-13 | 에지스 지오기스제르기아르 니일바노산 무코도 레스즈베니타르사사그 | 혈소판 응집 억제제 약물의 결정성 다형체를 제조하는 방법 |
ES2387802T3 (es) | 2003-08-04 | 2012-10-02 | Wockhardt Limited | Procedimiento novedoso para la fabricación de bisulfato de (+)-(S)-clopidogrel forma I |
DE10337773A1 (de) * | 2003-08-13 | 2005-03-24 | Krka Tovarna Zdravil, D.D. | Kristallisation von festen Formen von Clopidogrel-Additionssalzen |
US7629465B2 (en) * | 2004-03-05 | 2009-12-08 | Ipca Laboratories Ltd. | Industrial process for preparation of Clopidogrel hydrogen sulphate |
-
2005
- 2005-04-19 WO PCT/EP2005/004160 patent/WO2005100364A1/fr active Application Filing
- 2005-04-19 PL PL05734224.8T patent/PL1740593T3/pl unknown
- 2005-04-19 HU HUE05734224A patent/HUE029459T2/en unknown
- 2005-04-19 SI SI200532079A patent/SI1740593T1/sl unknown
- 2005-04-19 EA EA200601822A patent/EA010198B1/ru not_active IP Right Cessation
- 2005-04-19 ES ES05734224.8T patent/ES2577303T3/es active Active
- 2005-04-19 EP EP05734224.8A patent/EP1740593B1/fr active Active
- 2005-04-19 US US11/568,075 patent/US7999106B2/en not_active Expired - Fee Related
-
2006
- 2006-11-20 NO NO20065321A patent/NO339878B1/no not_active IP Right Cessation
-
2016
- 2016-06-28 HR HRP20160757TT patent/HRP20160757T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
ES2577303T3 (es) | 2016-07-14 |
US7999106B2 (en) | 2011-08-16 |
NO20065321L (no) | 2007-01-09 |
HRP20160757T1 (hr) | 2016-08-12 |
EP1740593B1 (fr) | 2016-04-06 |
EA200601822A1 (ru) | 2007-02-27 |
WO2005100364A1 (fr) | 2005-10-27 |
EA010198B1 (ru) | 2008-06-30 |
EP1740593A1 (fr) | 2007-01-10 |
NO339878B1 (no) | 2017-02-13 |
US20090234123A1 (en) | 2009-09-17 |
SI1740593T1 (sl) | 2016-08-31 |
PL1740593T3 (pl) | 2016-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUE029459T2 (en) | Methods for the Preparation of Polymorph Form I of Clopidogrel Hydrogen Sulphate | |
KR100649500B1 (ko) | 디할로겐화 아다만탄의 제조 방법 | |
JP2001525817A (ja) | 新規中間体及びこれらの調製方法 | |
JPS6014030B2 (ja) | 抗抑うつ症剤の製造方法 | |
JPS606332B2 (ja) | パ−フルオロアルキル基を有するカルボン酸又はスルフイン酸誘導体の製造法 | |
US7109353B2 (en) | Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCl | |
EP3950666B1 (fr) | Composé diène conjugué halogéné, préparation et utilisation associées | |
CN112939922A (zh) | 一种1-氰基-6-甲基磺酰基-7-硝基-9h-呫吨-9-酮的合成方法 | |
JPH0227994B2 (fr) | ||
US4288620A (en) | Process for the production of 4-acylamido-2-nitro-1-alkoxybenzenes | |
CN114591225B (zh) | 一种可规模化生产2,6-二溴-4-甲基吡啶的方法 | |
JP3640319B2 (ja) | ベンズアミド誘導体の製造方法 | |
CN114634492B (zh) | 一种拉诺康唑的制备方法 | |
JPH06737B2 (ja) | アルキル―〔3クロロフェニル〕―スルホンの製造方法 | |
EP3950665B1 (fr) | Composé de type triène conjugué, son procédé de préparation et son utilisation | |
EP2385045B1 (fr) | Procédé de production d'un composé de dibenzoxépine | |
US20050171145A1 (en) | Process for the preparation of 2-(ethoxymethyl)-tropane derivatives | |
CN108586333A (zh) | 二氯喹啉草酮的合成方法 | |
GB2290790A (en) | Asymmetric synthesis of 6-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes | |
CN109400489B (zh) | 一种盐酸甲氯芬酯的制备方法 | |
US4820852A (en) | Process for the preparation of diacyl-dianhydro hexitols | |
JPH05178833A (ja) | N−シアノアセトアミジン誘導体の製造方法 | |
KR830002203B1 (ko) | 이소프로필 4, 10-디하이드로-10-옥소티에노[3, 2-c][1] 벤즈옥세핀-8-아세테이트의 제조방법 | |
JPS6241501B2 (fr) | ||
JP2590436B2 (ja) | ジフェニルジスルホニルフルオライドの合成方法 |